147 related articles for article (PubMed ID: 6098315)
1. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
Rybalkin SD; Kurennaia GS; Sobolev AS
Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
[TBL] [Abstract][Full Text] [Related]
2. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
Sobolev AS; Rybalkin SD
Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
[TBL] [Abstract][Full Text] [Related]
3. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
4. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
5. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
6. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
Tertrin-Clary C; Chenut MC; Acker G; De La Llosa P
Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
[TBL] [Abstract][Full Text] [Related]
7. [Changes in the ratio of cyclic nucleotide phosphodiesterase forms in the thymocytes of irradiated mice].
Rybalkin SD; Sobolev AS
Radiobiologiia; 1986; 26(2):167-70. PubMed ID: 3010370
[TBL] [Abstract][Full Text] [Related]
8. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
Hait WN; Weiss B
Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
[No Abstract] [Full Text] [Related]
10. Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms.
Keravis TM; Wells JN; Hardman JG
Biochim Biophys Acta; 1980; 613(1):116-29. PubMed ID: 6246952
[TBL] [Abstract][Full Text] [Related]
11. [Properties of cyclic nucleotide phosphodiesterase of the rabbit myometrium in various functional states].
Kurskiĭ MD; Osipenko AA; Prishchepa LA
Biokhimiia; 1984 Jul; 49(7):1096-102. PubMed ID: 6089916
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
Ilien B; Landry Y
Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
[No Abstract] [Full Text] [Related]
13. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
Grewal J; Karuppiah N; Mutus B
Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
[TBL] [Abstract][Full Text] [Related]
14. Properties of multiple kinetic forms of soluble cyclic nucleotide phosphodiesterase activity of rat colonic mucosa.
Craven PA; Neidig M; DeRubertis FR
Biochim Biophys Acta; 1983 May; 744(3):265-75. PubMed ID: 6303428
[TBL] [Abstract][Full Text] [Related]
15. Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: new factors modulating enzyme activity.
Galoyan AA; Gurvitz BYa
Neurochem Res; 1985 Nov; 10(11):1467-81. PubMed ID: 3003614
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
[TBL] [Abstract][Full Text] [Related]
17. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
18. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
Epstein PM; Mills JS; Ross CP; Strada SJ; Hersh EM; Thompson WJ
Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126
[No Abstract] [Full Text] [Related]
19. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
Strada SJ; Martin MW; Thompson WJ
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
[No Abstract] [Full Text] [Related]
20. [The process of cyclic adenosine-3',5'-monophosphate phosphodiesterase activation by 2',5'-oligoadenylate].
Tunitskaia VL; Itkes AV; Kochetkova MN; Severin ES
Biokhimiia; 1983 Oct; 48(10):1721-5. PubMed ID: 6315087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
